Cargando…
MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
BACKGROUND: Triple-negative breast cancer (TNBC) is highly invasive and aggressive and lacks specific molecular targets to improve the prognosis. MiR-25-3p promotes proliferation of many tumors and its role and underlying mechanisms in TNBC remain to be well elucidated. METHODS: Differential express...
Autores principales: | Chen, Hua, Pan, Hong, Qian, Yi, Zhou, Wenbin, Liu, Xiaoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759260/ https://www.ncbi.nlm.nih.gov/pubmed/29310680 http://dx.doi.org/10.1186/s12943-017-0754-0 |
Ejemplares similares
-
miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
por: Kong, Peng, et al.
Publicado: (2018) -
TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2
por: He, Guoqing, et al.
Publicado: (2021) -
MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway
por: Xie, Yingjun, et al.
Publicado: (2019) -
DSCR9/miR-21-5p axis inhibits pancreatic cancer proliferation and resistance to gemcitabine via BTG2 signaling: DSCR9/miR-21-5p/BTG2 regulates pancreatic cancer
por: Huang, Hui, et al.
Publicado: (2022) -
miR-497 inhibits proliferation and invasion in triple-negative breast cancer cells via YAP1
por: Li, Yuan, et al.
Publicado: (2021)